Cargando…

Early defects in mucopolysaccharidosis type IIIC disrupt excitatory synaptic transmission

The majority of patients affected with lysosomal storage disorders (LSD) exhibit neurological symptoms. For mucopolysaccharidosis type IIIC (MPSIIIC), the major burdens are progressive and severe neuropsychiatric problems and dementia, primarily thought to stem from neurodegeneration. Using the MPSI...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pará, Camila, Bose, Poulomee, Bruno, Luigi, Freemantle, Erika, Taherzadeh, Mahsa, Pan, Xuefang, Han, Chanshuai, McPherson, Peter S., Lacaille, Jean-Claude, Bonneil, Éric, Thibault, Pierre, O’Leary, Claire, Bigger, Brian, Morales, Carlos Ramon, Di Cristo, Graziella, Pshezhetsky, Alexey V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Clinical Investigation 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8410035/ https://www.ncbi.nlm.nih.gov/pubmed/34156977 http://dx.doi.org/10.1172/jci.insight.142073

Ejemplares similares

Glucosamine amends CNS pathology in mucopolysaccharidosis IIIC mouse expressing misfolded HGSNAT
por: Pan, Xuefang, et al.
Publicado: (2022)

Intraparenchymal convection enhanced delivery of AAV in sheep to treat Mucopolysaccharidosis IIIC
por: O’Leary, Claire, et al.
Publicado: (2023)

Neuropathophysiology of Lysosomal Storage Diseases: Synaptic Dysfunction as a Starting Point for Disease Progression
por: Pará, Camila, et al.
Publicado: (2020)

Characterization of the Biosynthesis, Processing and Kinetic Mechanism of Action of the Enzyme Deficient in Mucopolysaccharidosis IIIC
por: Fan, Xiaolian, et al.
Publicado: (2011)

Identification of age-dependent motor and neuropsychological behavioural abnormalities in a mouse model of Mucopolysaccharidosis Type II
por: Gleitz, Hélène F. E., et al.
Publicado: (2017)

Progressive neurologic and somatic disease in a novel mouse model of human mucopolysaccharidosis type IIIC
por: Marcó, Sara, et al.
Publicado: (2016)

Strategies for the Induction of Immune Tolerance to Enzyme Replacement Therapy in Mucopolysaccharidosis Type I
por: Ghosh, Arunabha, et al.
Publicado: (2019)

The First Korean Case of Mucopolysaccharidosis IIIC (Sanfilippo Syndrome Type C) Confirmed by Biochemical and Molecular Investigation
por: Huh, Hee Jae, et al.
Publicado: (2013)

Protein Misfolding as an Underlying Molecular Defect in Mucopolysaccharidosis III Type C
por: Feldhammer, Matthew, et al.
Publicado: (2009)

Brain‐targeted stem cell gene therapy corrects mucopolysaccharidosis type II via multiple mechanisms
por: Gleitz, Hélène FE, et al.
Publicado: (2018)

Non-syndromic retinitis pigmentosa due to mutations in the mucopolysaccharidosis type IIIC gene, heparan-alpha-glucosaminide N-acetyltransferase (HGSNAT)
por: Haer-Wigman, Lonneke, et al.
Publicado: (2015)

Crosstalk between 2 organelles: Lysosomal storage of heparan sulfate causes mitochondrial defects and neuronal death in mucopolysaccharidosis III type C
por: Pshezhetsky, Alexey V
Publicado: (2015)

Haematopoietic stem cell gene therapy with IL‐1Ra rescues cognitive loss in mucopolysaccharidosis IIIA
por: Parker, Helen, et al.
Publicado: (2020)

Assessment of Sleep in Children with Mucopolysaccharidosis Type III
por: Mahon, Louise Victoria, et al.
Publicado: (2014)

Novel small molecule TRVA242 targets neuromuscular junction in amyotrophic lateral sclerosis
por: Bose, Poulomee
Publicado: (2019)

Positive Regulation of Insulin Signaling by Neuraminidase 1
por: Dridi, Larbi, et al.
Publicado: (2013)

An investigation of the middle and late behavioural phenotypes of Mucopolysaccharidosis Type-III
por: Cross, Elaine M, et al.
Publicado: (2014)

RETRACTED: An Innovative Tool for Evidence-Based, Personalized Treatment Trials in Mucopolysaccharidosis
por: Wiesinger, Anna-Maria, et al.
Publicado: (2023)

521. Investigating the Gram-Positive Selective Spectrum of Ibezapolstat, a First-in-Class DNA Polymerase IIIC (Pol IIIC) Inhibitor
por: Jahangir Alam, M, et al.
Publicado: (2022)

The Interplay of Glycosaminoglycans and Cysteine Cathepsins in Mucopolysaccharidosis
por: David, Alexis, et al.
Publicado: (2023)

Recommendations on clinical trial design for treatment of Mucopolysaccharidosis Type III
por: Ghosh, Arunabha, et al.
Publicado: (2017)

Current and Future Treatment of Mucopolysaccharidosis (MPS) Type II: Is Brain-Targeted Stem Cell Gene Therapy the Solution for This Devastating Disorder?
por: Horgan, Claire, et al.
Publicado: (2022)

Actigraphic investigation of circadian rhythm functioning and activity levels in children with mucopolysaccharidosis type III (Sanfilippo syndrome)
por: Mumford, Rachel A., et al.
Publicado: (2015)

Somatostatin contributes to long-term potentiation at excitatory synapses onto hippocampal somatostatinergic interneurons
por: Racine, Anne-Sophie, et al.
Publicado: (2021)

Neuropathology in Mouse Models of Mucopolysaccharidosis Type I, IIIA and IIIB
por: Wilkinson, Fiona L., et al.
Publicado: (2012)

TRPC1 mediates slow excitatory synaptic transmission in hippocampal oriens/alveus interneurons
por: Kougioumoutzakis, André, et al.
Publicado: (2020)

Substrate accumulation and extracellular matrix remodelling promote persistent upper airway disease in mucopolysaccharidosis patients on enzyme replacement therapy
por: Pal, Abhijit Ricky, et al.
Publicado: (2018)

Stimulation of protein synthesis by optogenetic and chemical induction of excitatory synaptic plasticity in hippocampal somatostatin interneurons
por: Honoré, Ève, et al.
Publicado: (2022)

A rare case of autoimmune polyglandular syndrome type IIIc
por: Arya, Rajesh Kumar, et al.
Publicado: (2012)

Abstract: Reconstruction of Gustilo Type IIIC Injuries of the Lower Extremity
por: Abdou, Salma A., et al.
Publicado: (2018)

Object location learning in mice requires hippocampal somatostatin interneuron activity and is facilitated by mTORC1-mediated long-term potentiation of their excitatory synapses
por: Honoré, Eve, et al.
Publicado: (2022)

Mucopolysaccharidosis VI
por: Valayannopoulos, Vassili, et al.
Publicado: (2010)

Cathepsin B-associated Activation of Amyloidogenic Pathway in Murine Mucopolysaccharidosis Type I Brain Cortex
por: Viana, Gustavo Monteiro, et al.
Publicado: (2020)

Female Mucopolysaccharidosis IIIA Mice Exhibit Hyperactivity and a Reduced Sense of Danger in the Open Field Test
por: Langford-Smith, Alex, et al.
Publicado: (2011)

Heparan Sulfate Inhibits Hematopoietic Stem and Progenitor Cell Migration and Engraftment in Mucopolysaccharidosis I
por: Watson, H. Angharad, et al.
Publicado: (2014)

Severe kidney dysfunction in sialidosis mice reveals an essential role for neuraminidase 1 in reabsorption
por: Kho, Ikhui, et al.
Publicado: (2023)

Stage IIIC endometrial cancer review: Current controversies in adjuvant therapy
por: Buras, Andrea L., et al.
Publicado: (2021)

Curative treatment for stage IIIC2 cervical cancer: what to expect?
por: Mauro, Geovanne Pedro, et al.
Publicado: (2023)

Opponent control of behavioral reinforcement by inhibitory and excitatory projections from the ventral pallidum
por: Faget, Lauren, et al.
Publicado: (2018)

Airway Abnormalities in Adult Mucopolysaccharidosis and Development of Salford Mucopolysaccharidosis Airway Score
por: Gadepalli, Chaitanya, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_47rrpra8kt5n4fvdv7ebs8f9b0